School of Biomolecular and Biomedical Science, Conway Institute, University College Dublin, Dublin, Ireland.
FEBS J. 2011 Jul;278(14):2460-8. doi: 10.1111/j.1742-4658.2011.08172.x. Epub 2011 May 31.
Clostridial glutamate dehydrogenase mutants, designed to accommodate the 2'-phosphate of disfavoured NADPH, showed the expected large specificity shifts with NAD(P)H. Puzzlingly, similar assays with oxidized cofactors initially revealed little improvement with NADP(+) , although rates with NAD(+) were markedly diminished. This article reveals that the enzyme's discrimination in favour of NAD(+) and against NADP(+) had been greatly underestimated and has indeed been abated by a factor of > 16,000 by the mutagenesis. Initially, stopped-flow studies of the wild-type enzyme showed a burst increase of A(340) with NADP(+) but not NAD(+), with amplitude depending on the concentration of the coenzyme, rather than enzyme. Amplitude also varied with the commercial source of the NADP(+). FPLC, HPLC and mass spectrometry identified NAD(+) contamination ranging from 0.04 to 0.37% in different commercial samples. It is now clear that apparent rates of NADP(+) utilization mainly reflected the reduction of contaminating NAD(+), creating an entirely false view of the initial coenzyme specificity and also of the effects of mutagenesis. Purification of the NADP(+) eliminated the burst. With freshly purified NADP(+), the NAD(+) : NADP(+) activity ratio under standard conditions, previously estimated as 300 : 1, is 11,000. The catalytic efficiency ratio is even higher at 80,000. Retested with pure cofactor, mutants showed marked specificity shifts in the expected direction, for example, 16 200 fold change in catalytic efficiency ratio for the mutant F238S/P262S, confirming that the key structural determinants of specificity have been successfully identified. Of wider significance, these results underline that, without purification, even the best commercial coenzyme preparations are inadequate for such studies.
梭菌谷氨酸脱氢酶突变体,设计用于容纳不利的 NADPH 的 2'-磷酸,在与 NAD(P)H 反应时显示出预期的大特异性变化。令人费解的是,最初用氧化辅因子进行类似的测定时,发现 NADP(+)的改善很小,尽管 NAD(+)的速率明显降低。本文揭示了酶对 NAD(+)的选择性和对 NADP(+)的选择性已经被大大低估,并且通过突变已经被降低了 >16000 倍。最初,对野生型酶的停流研究表明,NADP(+)会导致 A(340)的爆发性增加,但 NAD(+)不会,其幅度取决于辅因子的浓度,而不是酶的浓度。幅度也随 NADP(+)的商业来源而变化。FPLC、HPLC 和质谱鉴定出不同商业样品中 NAD(+)的污染范围从 0.04%到 0.37%不等。现在很清楚,表观 NADP(+)利用率主要反映了污染 NAD(+)的还原,这就完全错误地反映了最初的辅酶特异性,也反映了诱变的影响。NADP(+)的纯化消除了爆发。用新纯化的 NADP(+),在标准条件下,NAD(+):NADP(+)的活性比,以前估计为 300:1,现在为 11000。在 80000 倍的催化效率比更高。用纯辅因子重新测试时,突变体显示出预期方向的显著特异性变化,例如,突变体 F238S/P262S 的催化效率比变化 16200 倍,这证实了特异性的关键结构决定因素已成功确定。更广泛的意义是,这些结果强调,如果不进行纯化,即使是最好的商业辅因子制剂也不足以进行此类研究。